Flow Cytometry Method Validation Protocols.


Journal

Current protocols in cytometry
ISSN: 1934-9300
Titre abrégé: Curr Protoc Cytom
Pays: United States
ID NLM: 100899351

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 13 11 2018
medline: 8 6 2019
entrez: 13 11 2018
Statut: ppublish

Résumé

Analytical method validation provides a means to ensure that data are credible and reproducible. This unit will provide a brief introduction to analytical method validation as applied to cellular analysis by flow cytometry. In addition, the unit will provide practical procedures for three different types of validation. The first is a limited validation protocol that is applicable for research settings and non-regulated laboratories. The second is validation protocol that presents the minimum validation requirements in regulated laboratories. The third is a transfer validation protocol to be used when methods are transferred between laboratories. The recommendations presented in this unit are consistent with the white papers published by the American Association of Pharmaceutical Scientists and the International Clinical Cytometry Society, as well as with Clinical Laboratory Standards Institute Guideline H62: Validation of Assays Performed by Flow Cytometry (currently in preparation). © 2018 by John Wiley & Sons, Inc.

Identifiants

pubmed: 30418706
doi: 10.1002/cpcy.53
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e53

Informations de copyright

© 2018 John Wiley & Sons, Inc.

Auteurs

Nithianandan Selliah (N)

Covance Central Laboratories, Indianapolis, Indiana.

Steven Eck (S)

MedImmune, Gaithersburg, Maryland.

Cherie Green (C)

Genentech, Inc., A Member of the Roche Group, Development Sciences Department, South San Francisco, California.

Teri Oldaker (T)

Independent Consultant, San Clemente, California.

Jennifer Stewart (J)

Flow Contract Site Laboratory, LLC, Bothell, Washington.

Alessandra Vitaliti (A)

Novartis Institute for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.

Virginia Litwin (V)

Caprion Biosciences, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH